{"id":12897,"date":"2019-07-31T13:01:25","date_gmt":"2019-07-31T11:01:25","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=12897"},"modified":"2019-07-31T13:12:21","modified_gmt":"2019-07-31T11:12:21","slug":"litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/","title":{"rendered":"L’Italia e la scarsa diffusione dei farmaci “no brand”"},"content":{"rendered":"\n

photo by Brett Jordan <\/p>\n\n\n\n

Agli italiani continuano a piacere i farmaci “griffati”, anche se i generici costano dal 20 al 50% in meno e hanno la medesima efficacia. “Per favore non mi dia il generico” \u00e8 una delle frasi che i farmacisti sentono pi\u00f9 spesso dire dai loro clienti, ancora molto restii e diffidenti all’acquisto dei prodotti no brand.<\/p>\n\n\n\n

Dal rapporto Osmed dell’AIFA, \u00e8 chiaro che nel 2018 solo il 30% degli 1,608 miliardi di euro sborsati per il ticket sui farmaci \u00e8 relativo alla quota fissa per ricetta (8 euro pro capite), e che il rimanente 70%, ovvero 1,126 milioni (18,6 euro pro capite) \u00e8 invece imputabile alla scarsa diffusione dei no brand. Non stupisce quindi che, secondo l’Ocse, Italia \u00e8 al penultimo posto su 27 Paesi.<\/p>\n\n\n\n

La Fondazione Gimbe, integrando i dati del rapporto 2019, certifica questa tendenza al rifiuto del generico, tutta italiana.
Nel report<\/a> della Fondazione Gimbe si calcola tra l’altro che la spesa per il ticket dei farmaci \u00e8 aumentata del 12% rispetto al 2014. Ma questo accade perch\u00e8 \u00e8 aumentato il numero di farmaci “griffati” e non la quantit\u00e0 dei pi\u00f9 economici generici. “Spicca – sottolinea il presidente della Fondazione Gimbe, Nino Cartabellotta – l’ostinata e ingiustificata resistenza ai farmaci equivalenti nelle Regioni del Centro-Sud nelle quali si rileva una spesa per i farmaci di marca pi\u00f9 elevata della media nazionale”.
In particolare, la regione dove si spende di pi\u00f9 pur di avere un farmaco di marca \u00e8 il Lazio, dove si calcola una spesa per quelli di marca superiore di 24,7 euro pro capite all’ anno. Seguono la Sicilia, la Calabria e la Campania.<\/p>\n","protected":false},"excerpt":{"rendered":"

photo by Brett Jordan Agli italiani continuano a piacere i farmaci “griffati”, anche se i generici costano dal 20 al 50% in meno e hanno la medesima efficacia. “Per favore non mi dia il generico” \u00e8 una delle frasi che i farmacisti sentono pi\u00f9 spesso dire dai loro clienti, ancora molto restii e diffidenti all’acquisto dei prodotti no brand. Dal rapporto Osmed dell’AIFA, \u00e8 chiaro che nel 2018 solo il 30% degli 1,608 miliardi di euro sborsati per il ticket…<\/p>\n","protected":false},"author":297440,"featured_media":12898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[],"class_list":["post-12897","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nL'Italia e la scarsa diffusione dei farmaci "no brand" - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L'Italia e la scarsa diffusione dei farmaci "no brand" - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by Brett Jordan Agli italiani continuano a piacere i farmaci “griffati”, anche se i generici costano dal 20 al 50% in meno e hanno la medesima efficacia. “Per favore non mi dia il generico” \u00e8 una delle frasi che i farmacisti sentono pi\u00f9 spesso dire dai loro clienti, ancora molto restii e diffidenti all’acquisto dei prodotti no brand. Dal rapporto Osmed dell’AIFA, \u00e8 chiaro che nel 2018 solo il 30% degli 1,608 miliardi di euro sborsati per il ticket...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-31T11:01:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-07-31T11:12:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"L’Italia e la scarsa diffusione dei farmaci “no brand”\",\"datePublished\":\"2019-07-31T11:01:25+00:00\",\"dateModified\":\"2019-07-31T11:12:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/\"},\"wordCount\":264,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/\",\"name\":\"L'Italia e la scarsa diffusione dei farmaci \\\"no brand\\\" - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg\",\"datePublished\":\"2019-07-31T11:01:25+00:00\",\"dateModified\":\"2019-07-31T11:12:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg\",\"width\":1200,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L’Italia e la scarsa diffusione dei farmaci “no brand”\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'Italia e la scarsa diffusione dei farmaci \"no brand\" - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/","og_locale":"en_US","og_type":"article","og_title":"L'Italia e la scarsa diffusione dei farmaci \"no brand\" - Frezza Partners","og_description":"photo by Brett Jordan Agli italiani continuano a piacere i farmaci “griffati”, anche se i generici costano dal 20 al 50% in meno e hanno la medesima efficacia. “Per favore non mi dia il generico” \u00e8 una delle frasi che i farmacisti sentono pi\u00f9 spesso dire dai loro clienti, ancora molto restii e diffidenti all’acquisto dei prodotti no brand. Dal rapporto Osmed dell’AIFA, \u00e8 chiaro che nel 2018 solo il 30% degli 1,608 miliardi di euro sborsati per il ticket...","og_url":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/","og_site_name":"Frezza Partners","article_published_time":"2019-07-31T11:01:25+00:00","article_modified_time":"2019-07-31T11:12:21+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"L’Italia e la scarsa diffusione dei farmaci “no brand”","datePublished":"2019-07-31T11:01:25+00:00","dateModified":"2019-07-31T11:12:21+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/"},"wordCount":264,"commentCount":0,"image":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/","url":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/","name":"L'Italia e la scarsa diffusione dei farmaci \"no brand\" - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg","datePublished":"2019-07-31T11:01:25+00:00","dateModified":"2019-07-31T11:12:21+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2019\/07\/brett-jordan-pDFJp1u0prE-unsplash-e1564571530603.jpg","width":1200,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/litalia-e-la-scarsa-diffusione-dei-farmaci-no-brand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"L’Italia e la scarsa diffusione dei farmaci “no brand”"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/12897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=12897"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/12897\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/12898"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=12897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=12897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=12897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}